Depression and chronic kidney disease: A review for clinicians

Alison Bautovich1, Ivor Katz2, Michelle Smith3

  • 1School of Psychiatry, University of New South Wales, Sydney, Australia NSW Institute of Psychiatry, Westmead, Australia St George Hospital, Kogarah, Australia a.bautovich@unsw.edu.au.

Insights

Depression is prevalent in chronic kidney disease (CKD), affecting about 20% of patients and leading to poorer health outcomes. Further research is needed to establish effective treatments for depression in CKD patients.

Area of Science:

  • Nephrology
  • Psychiatry
  • Clinical Medicine

Background:

  • Depression is a significant comorbidity in patients with chronic kidney disease (CKD).
  • The prevalence, causes, and consequences of depression in CKD are complex and multifactorial.
  • Existing literature highlights the adverse impact of depression on CKD patient outcomes.

Purpose of the Study:

  • To synthesize recent literature on depression in CKD, covering prevalence, etiology, associations, and management.
  • To offer clinicians a practical and current resource for managing depression in CKD patients.
  • To identify gaps in current research and guide future clinical practice.

Main Methods:

  • Comprehensive literature search of MEDLINE, EMBASE, and PsycINFO databases.
  • Utilized search terms including "depression," "mood disorders," and "mental illness" combined with "kidney disease," "renal insufficiency," "dialysis," and "kidney failure."
  • Specific searches were conducted for studies on antidepressant use in CKD.

Main Results:

  • Recent studies confirm significantly elevated depression rates in CKD patients, with meta-analyses indicating approximately 20% prevalence.
  • Depression in CKD is linked to adverse outcomes such as increased mortality, hospitalization, reduced treatment adherence, and lower quality of life.
  • While clinical assessment can be challenging, various treatment options are available once depression is diagnosed.

Conclusions:

  • Depression is a common and serious condition in individuals with CKD, associated with substantial risks.
  • There is an urgent need for rigorous randomized controlled trials to evaluate interventions for depression in CKD.
  • Such trials are crucial for determining the safety and efficacy of treatments, improving patient care.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.4K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
682
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.8K
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
527